tiprankstipranks
Trending News
More News >
Optimizerx Corporation (OPRX)
:OPRX
US Market

OptimizeRx (OPRX) Stock Forecast & Price Target

Compare
502 Followers
See the Price Targets and Ratings of:

OPRX Analyst Ratings

Strong Buy
6Ratings
Strong Buy
6 Buy
0 Hold
0 Sell
Based on 6 analysts giving stock ratings to
OptimizeRx
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

OPRX Stock 12 Month Forecast

Average Price Target

$16.50
▲(35.91%Upside)
Based on 6 Wall Street analysts offering 12 month price targets for OptimizeRx in the last 3 months. The average price target is $16.50 with a high forecast of $22.00 and a low forecast of $12.50. The average price target represents a 35.91% change from the last price of $12.14.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"3":"$3","8":"$8","13":"$13","18":"$18","23":"$23"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":22,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$22.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":16.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$16.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":12.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$12.50</span>\n  </div></div>","useHTML":true}}],"tickPositions":[3,8,13,18,23],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2024","6":"Nov<br/>2024","9":"Feb<br/>2025","12":"May<br/>2025","25":"May<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,9.64,10.590769230769231,11.541538461538462,12.492307692307692,13.443076923076923,14.393846153846155,15.344615384615384,16.295384615384616,17.246153846153845,18.196923076923078,19.14769230769231,20.09846153846154,21.049230769230768,{"y":22,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,9.64,10.167692307692308,10.695384615384615,11.223076923076924,11.750769230769231,12.278461538461539,12.806153846153848,13.333846153846155,13.861538461538462,14.38923076923077,14.916923076923077,15.444615384615386,15.972307692307693,{"y":16.5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,9.64,9.860000000000001,10.08,10.3,10.52,10.74,10.96,11.18,11.4,11.620000000000001,11.84,12.06,12.28,{"y":12.5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":11.42,"date":1711929600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.42,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.06,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.99,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.49,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.31,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.15,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.52,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.86,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.55,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.18,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.18,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.64,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$22.00Average Price Target$16.50Lowest Price Target$12.50
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on OPRX
TipRanks AITipRanks
Not Ranked
TipRanks
$11
Buy
-9.39%
Downside
Reiterated
05/15/25
OptimizeRx receives a moderately strong overall score due to positive revenue trends and operational improvements reflected in recent earnings. However, persistent profitability issues and negative valuation metrics limit the score. Strong technical indicators and strategic leadership changes offer potential for future growth.
Roth MKM
$16$22
Buy
81.22%
Upside
Reiterated
05/13/25
OptimizeRx (OPRX) Gets a Buy from Roth MKM
Lake Street Analyst forecast on OPRX
Eric MartinuzziLake Street
Lake Street
$16
Buy
31.80%
Upside
Reiterated
05/13/25
Lake Street Remains a Buy on OptimizeRx (OPRX)
Stifel Nicolaus Analyst forecast on OPRX
David GrossmanStifel Nicolaus
Stifel Nicolaus
$8$12.5
Buy
2.97%
Upside
Reiterated
05/13/25
OptimizeRx price target raised to $12.50 from $8 at StifelOptimizeRx price target raised to $12.50 from $8 at Stifel
B.Riley Financial Analyst forecast on OPRX
Anderson SchockB.Riley Financial
B.Riley Financial
$13$18
Buy
48.27%
Upside
Reiterated
05/13/25
OptimizeRx price target raised to $18 from $13 at B. RileyOptimizeRx price target raised to $18 from $13 at B. Riley
Citizens JMP
$11$14
Buy
15.32%
Upside
Reiterated
05/13/25
OptimizeRx price target raised to $14 from $11 at Citizens JMPOptimizeRx price target raised to $14 from $11 at Citizens JMP
William Blair Analyst forecast on OPRX
Ryan DanielsWilliam Blair
William Blair
Buy
Reiterated
05/12/25
OptimizeRx: Strong Financial Performance and Strategic Growth Positioning for Potential Acquisition
RBC Capital Analyst forecast on OPRX
Sean DodgeRBC Capital
RBC Capital
$6
Hold
-50.58%
Downside
Downgraded
01/08/25
OptimizeRx (OPRX) was downgraded to a Hold Rating at RBC Capital
Stephens
$5.5
Hold
-54.70%
Downside
Initiated
12/19/24
OptimizeRx initiated with an Equal Weight at StephensOptimizeRx initiated with an Equal Weight at Stephens
Barclays
$5
Hold
-58.81%
Downside
Reiterated
11/14/24
Barclays Sticks to Their Hold Rating for OptimizeRx (OPRX)
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on OPRX
TipRanks AITipRanks
Not Ranked
TipRanks
$11
Buy
-9.39%
Downside
Reiterated
05/15/25
OptimizeRx receives a moderately strong overall score due to positive revenue trends and operational improvements reflected in recent earnings. However, persistent profitability issues and negative valuation metrics limit the score. Strong technical indicators and strategic leadership changes offer potential for future growth.
Roth MKM
$16$22
Buy
81.22%
Upside
Reiterated
05/13/25
OptimizeRx (OPRX) Gets a Buy from Roth MKM
Lake Street Analyst forecast on OPRX
Eric MartinuzziLake Street
Lake Street
$16
Buy
31.80%
Upside
Reiterated
05/13/25
Lake Street Remains a Buy on OptimizeRx (OPRX)
Stifel Nicolaus Analyst forecast on OPRX
David GrossmanStifel Nicolaus
Stifel Nicolaus
$8$12.5
Buy
2.97%
Upside
Reiterated
05/13/25
OptimizeRx price target raised to $12.50 from $8 at StifelOptimizeRx price target raised to $12.50 from $8 at Stifel
B.Riley Financial Analyst forecast on OPRX
Anderson SchockB.Riley Financial
B.Riley Financial
$13$18
Buy
48.27%
Upside
Reiterated
05/13/25
OptimizeRx price target raised to $18 from $13 at B. RileyOptimizeRx price target raised to $18 from $13 at B. Riley
Citizens JMP
$11$14
Buy
15.32%
Upside
Reiterated
05/13/25
OptimizeRx price target raised to $14 from $11 at Citizens JMPOptimizeRx price target raised to $14 from $11 at Citizens JMP
William Blair Analyst forecast on OPRX
Ryan DanielsWilliam Blair
William Blair
Buy
Reiterated
05/12/25
OptimizeRx: Strong Financial Performance and Strategic Growth Positioning for Potential Acquisition
RBC Capital Analyst forecast on OPRX
Sean DodgeRBC Capital
RBC Capital
$6
Hold
-50.58%
Downside
Downgraded
01/08/25
OptimizeRx (OPRX) was downgraded to a Hold Rating at RBC Capital
Stephens
$5.5
Hold
-54.70%
Downside
Initiated
12/19/24
OptimizeRx initiated with an Equal Weight at StephensOptimizeRx initiated with an Equal Weight at Stephens
Barclays
$5
Hold
-58.81%
Downside
Reiterated
11/14/24
Barclays Sticks to Their Hold Rating for OptimizeRx (OPRX)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering OptimizeRx

1 Month
xxx
Success Rate
11/17 ratings generated profit
65%
Average Return
+6.88%
reiterated a xxx
rating 21 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 64.71% of your transactions generating a profit, with an average return of +6.88% per trade.
3 Months
xxx
Success Rate
7/10 ratings generated profit
70%
Average Return
+15.97%
reiterated a xxx
rating 21 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 70.00% of your transactions generating a profit, with an average return of +15.97% per trade.
1 Year
Success Rate
8/10 ratings generated profit
80%
Average Return
+64.78%
reiterated a buy rating 21 days ago
Copying Constantine Davides's trades and holding each position for 1 Year would result in 80.00% of your transactions generating a profit, with an average return of +64.78% per trade.
2 Years
xxx
Success Rate
9/10 ratings generated profit
90%
Average Return
+69.81%
reiterated a xxx
rating 21 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 90.00% of your transactions generating a profit, with an average return of +69.81% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

OPRX Analyst Recommendation Trends

Rating
Jan 25
Feb 25
Mar 25
Apr 25
May 25
Strong Buy
9
5
2
2
4
Buy
2
2
6
7
10
Hold
3
2
1
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
14
9
9
9
14
In the current month, OPRX has received 14 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. OPRX average Analyst price target in the past 3 months is 16.50.
Each month's total comprises the sum of three months' worth of ratings.

OPRX Financial Forecast

OPRX Earnings Forecast

Next quarter’s earnings estimate for OPRX is $0.02 with a range of $0.00 to $0.05. The previous quarter’s EPS was $0.08. OPRX beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 45.45% of the time in the same period. In the last calendar year OPRX has Outperformed its overall industry.
Next quarter’s earnings estimate for OPRX is $0.02 with a range of $0.00 to $0.05. The previous quarter’s EPS was $0.08. OPRX beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 45.45% of the time in the same period. In the last calendar year OPRX has Outperformed its overall industry.

OPRX Sales Forecast

Next quarter’s sales forecast for OPRX is $22.27M with a range of $22.00M to $22.89M. The previous quarter’s sales results were $21.93M. OPRX beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 57.14% of the time in the same period. In the last calendar year OPRX has Outperformed its overall industry.
Next quarter’s sales forecast for OPRX is $22.27M with a range of $22.00M to $22.89M. The previous quarter’s sales results were $21.93M. OPRX beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 57.14% of the time in the same period. In the last calendar year OPRX has Outperformed its overall industry.

OPRX Stock Forecast FAQ

What is OPRX’s average 12-month price target, according to analysts?
Based on analyst ratings, Optimizerx Corporation’s 12-month average price target is 16.50.
    What is OPRX’s upside potential, based on the analysts’ average price target?
    Optimizerx Corporation has 35.91% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is OPRX a Buy, Sell or Hold?
          Optimizerx Corporation has a consensus rating of Strong Buy which is based on 6 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Optimizerx Corporation’s price target?
            The average price target for Optimizerx Corporation is 16.50. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $22.00 ,the lowest forecast is $12.50. The average price target represents 35.91% Increase from the current price of $12.14.
              What do analysts say about Optimizerx Corporation?
              Optimizerx Corporation’s analyst rating consensus is a Strong Buy. This is based on the ratings of 6 Wall Streets Analysts.
                How can I buy shares of OPRX?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis